Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade + Thalidomide + Dexamethasone vs Thalidomide + Dexamethasone in Relapsed Myeloma
NCT00256776Phase 3Terminated
- Start
- Jul 2005
- Primary completion
- Dec 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM). Started Jul 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00256776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256776.